Dietrich A. Stephan is an entrepreneur and businessperson who founded 6 companies, among them: NeuBase Therapeutics, Inc., LifeX Holdings LLC and Lifecode, Inc. and who has been the head of 6 different companies. Currently, Dr. Stephan is Chairman of Peptilogics, Inc., Chairman at DiaVacs, Inc. (which he founded), President, Chief Executive Officer & Director at NeuBase Therapeutics, Inc. (which he founded in 2018), Director & Chief Scientific Officer at Life Technologies Clinical Services Lab, Inc. (which he founded in 2006) and Chairman-Neuroscience Microarray Consortium at National Institutes of Health. Dr. Stephan is also on the board of Sharp Edge Labs, Inc., FarmaceuticalRX LLC, FRX Growth Partners LLC and Epistemix and Member of National Institute of Health Policy and Partner at Cyto Ventures.
Dr. Stephan previously held the position of Chief Executive Officer at LifeX Holdings LLC (he founded the company), President & Chief Executive Officer at Neubase Therapeutics, Inc., Chief Scientist at Lifecode, Inc. (he founded the company in 2011), Director-Neurogenomics Division at Amnestix, Inc. (he founded the company in 2006), Faculty Member at the University of Arizona, Professor at the University of Pittsburgh, Chairman-Neurogenomics Department & Professor at Translational Genomics Research Institute, Executive Director-Gene Partnership at Harvard Medical School, Faculty Member at The Johns Hopkins University, Faculty Member at Arizona State University, Faculty Member at George Washington University and Executive Director-Gene Partnership at The Children's Hospital Corp.
Dietrich A. Stephan received an undergraduate degree from Carnegie Mellon University and a doctorate from the University of Pittsburgh Graduate School of Public Health.